Register Login
Register to leave comments
  • News bot April 7, 2026, 12:36 p.m.

    📋 SS INNOVATIONS INTERNATIONAL, INC. (SSII) - Clinical Trial Update

    Filing Date: 2026-04-07

    Accepted: 2026-04-07 08:35:08

    Event Type: Clinical Trial Update

    Event Details:

    SS INNOVATIONS INTERNATIONAL, INC. (SSII) Announces Clinical Trial Update SS INNOVATIONS INTERNATIONAL, INC. (SSII) provided an update on its clinical development programs. Clinical Development Highlights:
    • Drug Program: experts
    • Diseases/Conditions: robotic surgery
    • Collaboration: the Forefront of Surgical Robotic Innovation Fort Lauderdale

    🔬 Clinical Development Pipeline (SS INNOVATIONS INTERNATIONAL, INC.):

    Product Type Development Stage Therapeutic Area Source
    Safety Planning Intervention BEHAVIORAL Approved HIV - Human Immunodeficiency Virus ClinicalTrials.gov
    IDEAS for Hope BEHAVIORAL Approved HIV - Human Immunodeficiency Virus ClinicalTrials.gov
    Transition Health and Resilience through Valued Experiences (THRiVE) Program BEHAVIORAL Approved Military Transition ClinicalTrials.gov
    Placebo OTHER Phase PHASE3 Preterm Birth ClinicalTrials.gov
    Oral nitrofurantoin monohydrate/macrocrystals DRUG Phase PHASE3 Preterm Birth ClinicalTrials.gov
    Bulkamid Transurethral Bulking Agent DEVICE Approved Stress Urinary Incontinence ClinicalTrials.gov
    Solyx Single-incision Sling DEVICE Approved Stress Urinary Incontinence ClinicalTrials.gov
    Postoperative Exercise regimen BEHAVIORAL Approved Pelvic Organ Prolapse ClinicalTrials.gov
    Usual Care BEHAVIORAL Approved Diabetes Mellitus ClinicalTrials.gov
    WW Intervention BEHAVIORAL Approved Diabetes Mellitus ClinicalTrials.gov
    Half-Day First Responder Training OTHER Approved Trauma ClinicalTrials.gov
    Diet C OTHER Approved Nutrition ClinicalTrials.gov
    Diet B OTHER Approved Nutrition ClinicalTrials.gov
    Diet A OTHER Approved Nutrition ClinicalTrials.gov
    Training as usual (TAU) BEHAVIORAL Approved Sexual Assault ClinicalTrials.gov
    Alcohol eCHECKUP TO GO (eCHECKUP TO GO) BEHAVIORAL Approved Sexual Assault ClinicalTrials.gov
    Sexual Communication and Consent (SCC) BEHAVIORAL Approved Sexual Assault ClinicalTrials.gov
    Couples Health CoOp Plus (CHC+) BEHAVIORAL Approved HIV ClinicalTrials.gov
    Community Stigma Awareness and Education Workshop BEHAVIORAL Approved HIV ClinicalTrials.gov
    One-time education OTHER Approved Cervical Cancer ClinicalTrials.gov
    ARROW strategies OTHER Approved Cervical Cancer ClinicalTrials.gov
    Responses to survey questions OTHER Preclinical Eating Behavior ClinicalTrials.gov
    C3Link Strategies BEHAVIORAL Approved Breast Cancer ClinicalTrials.gov
    HOPO 14-1 DRUG Phase PHASE1 Toxicity;Chemical ClinicalTrials.gov
    HealthSmart BEHAVIORAL Approved Gender-based Violence ClinicalTrials.gov
    Virtual Safe Dates for Young Parents BEHAVIORAL Approved Gender-based Violence ClinicalTrials.gov
    Safe Dates for Young Parents (SDYP) BEHAVIORAL Approved Gender-based Violence ClinicalTrials.gov
    External QI Facilitation BEHAVIORAL Approved Opioid Use Disorder ClinicalTrials.gov
    Quality Improvement (QI) Toolkit BEHAVIORAL Approved Opioid Use Disorder ClinicalTrials.gov
    Quality Measures (Audit and Feedback) BEHAVIORAL Approved Opioid Use Disorder ClinicalTrials.gov
    Relapse Prevention (RP) BEHAVIORAL Approved Alcohol Use Disorder ClinicalTrials.gov
    Behavioral Activation (BA) BEHAVIORAL Approved Alcohol Use Disorder ClinicalTrials.gov
    PARCA BEHAVIORAL Approved Behavioral Addiction ClinicalTrials.gov
    Video-counseling+app BEHAVIORAL Approved HIV/AIDS ClinicalTrials.gov
    Standard of Care OTHER Approved HIV/AIDS ClinicalTrials.gov
    Tu'Washindi BEHAVIORAL Approved IPV ClinicalTrials.gov
    Yttrium-90 Microsphere Radioembolization DEVICE Phase PHASE2 Metastatic Malignant Neoplasm in the Liver ClinicalTrials.gov
    Peptide Receptor Radionuclide Therapy (PRRT) using 177Lu-DOTA0-Tyr3-Octreotate BIOLOGICAL Phase PHASE2 Metastatic Malignant Neoplasm in the Liver ClinicalTrials.gov
    Pembrolizumab BIOLOGICAL Phase PHASE2 Metastatic Malignant Neoplasm in the Liver ClinicalTrials.gov
    Arterial Embolization PROCEDURE Phase PHASE2 Metastatic Malignant Neoplasm in the Liver ClinicalTrials.gov
    Placebo (plus placebo electrolyte solution) DRUG Phase PHASE4 Bronchopulmonary Dysplasia ClinicalTrials.gov
    Furosemide (plus potassium chloride) DRUG Phase PHASE4 Bronchopulmonary Dysplasia ClinicalTrials.gov
    Education OTHER Approved Urinary Incontinence ClinicalTrials.gov
    Home pelvic floor exercises guided by the leva® device DEVICE Approved Urinary Incontinence ClinicalTrials.gov
    Interventionist-guided training OTHER Approved Urinary Incontinence ClinicalTrials.gov
    tVNS, continuous stimulation DEVICE Phase PHASE3 Prader-Willi Syndrome ClinicalTrials.gov
    tVNS, intermittent stimulation DEVICE Phase PHASE3 Prader-Willi Syndrome ClinicalTrials.gov

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval: Not available
    • Executive Changes: Not available

    Structured Data:

    • Company Name: SS INNOVATIONS INTERNATIONAL, INC.
    • Ticker Symbol: SSII

Search

News categories